Operator
Good day, everyone, and welcome to today s Neurocrine Biosciences Reports Fourth Quarter and Year-End 2020 Results. [Operator Instructions] [Operator Instructions]
It is now my pleasure to turn the conference over to Vice President of Investor Relations, Todd Tushla.
Todd Tushla
Vice President of Investor Relations
Thank you, Clorey. Good afternoon, everyone, and thank you for joining us on our fourth quarter and full year 2020 earnings call. On the call today is Kevin Gorman, our Chief Executive Officer; Matt Abernethy, our Chief Financial Officer; Eiry Roberts, our Chief Medical Officer; Eric Benevich, our Chief Commercial Officer; and Kyle Gano, our Chief Business Development and Strategy Officer.